This 'de-activation' via a 'de novo' (i.e., new) mutation results in only half of SYNGAP1 messages ultimately being converted into the production of the SynGAP protein. As the SynGAP protein ...
Mill Valley, CA – February 11, 2025 – The SynGAP Research Fund 501(c)(3) dba Cure SYNGAP1 proudly announces the release of its inaugural Impact Report, a transparent and celebratory reporting ...